Holen Sie sich die Stockscreener-App
1.42
21.73%
-0.37
Schlusskurs vom Vortag:
$1.79
Offen:
$1.38
24-Stunden-Volumen:
1.81M
Relative Volume:
2.35
Marktkapitalisierung:
$99.38M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-0.9467
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-28.15%
1M Leistung:
-23.85%
6M Leistung:
-55.24%
1J Leistung:
-65.91%
1-Tages-Spanne:
$1.20
$1.4794
1-Wochen-Bereich:
$1.20
$1.92
52-Wochen-Spanne:
$1.20
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.405 | 126.61M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
179.10 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.78 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
37.66 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
75.88 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.23 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com
Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review - MSN
Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Health Catalyst (HCAT) Reports $311.1M Revenue for 2025, New Lea - GuruFocus
Health Catalyst Q4 Earnings Call Highlights - Yahoo Finance
Health Catalyst, Inc. 2025 Annual Report: Data-Driven Healthcare Improvement, Company Mission, and Growth Strategies - Minichart
Earnings call transcript: Health Catalyst Q4 2025 results show mixed performance - Investing.com
Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Health Catalyst Q4 2025 Financial Report: Revenue $74.7M, Loss $91MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Health Catalyst Q4 2025 Earnings: Revenue Beat, Lower Guidance for 2026News and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Health Catalyst (HCAT) Reports Strong Q4 Revenue and Outlines Fu - GuruFocus
Health Catalyst: Fourth Quarter Earnings Overview - Bitget
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Health Catalyst: Q4 Earnings Snapshot - kare11.com
Health Catalyst (NASDAQ:HCAT) Posts Better-Than-Expected Sales In Q4 CY2025 But Stock Drops 10.4% - TradingView
Health Catalyst (NASDAQ:HCAT) Announces Quarterly Earnings Results - MarketBeat
Health Catalyst Reports Fourth Quarter and Year End 2025 Results - The Manila Times
Health Catalyst (HCAT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
How The Health Catalyst (HCAT) Story Is Shifting After A Tough 2025 For Health Tech - Yahoo Finance
Health Catalyst (HCAT) Q4 Earnings: What To Expect - Yahoo Finance UK
Gear Up for Health Catalyst (HCAT) Q4 Earnings: Wall Street Estimates for Key Metrics - Yahoo Finance
Big Picture: Is Health Catalyst Inc. a top pick in the sectorTrade Signal Summary & Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Weekly: Does Health Catalyst Inc have a sustainable dividend2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Health Catalyst urges HIMSS26 attendees to prioritize performance metrics with expert strategy sessions - Traders Union
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst, AppLovin, PubMatic, and Pegasystems Stocks Trade Up, What You Need To Know - The Globe and Mail
Health Catalyst, AppLovin, PubMatic, and Pegasystems Shares Rise, Key Information to Consider - Bitget
Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - The Globe and Mail
Health Catalyst (HCAT) insider sale notice: 15,726 shares via Morgan Stanley on 03/02/2026 - Stock Titan
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026 - Bitget
How to listen to Health Catalyst’s March 12 results call - Stock Titan
Value Recap: Does Health Catalyst Inc outperform in volatile marketsMarket Activity Report & Capital Protection Trade Alerts - baoquankhu1.vn
Revenue per share of Health Catalyst, Inc. – DUS:2YP - TradingView
Primecap Management Co. CA Trims Stake in Health Catalyst - National Today
Primecap Management Co. CA Sells 617,620 Shares of Health Catalyst, Inc. $HCAT - MarketBeat
Health Catalyst (HCAT) CEO logs large RSU grants and tax-driven share sale - Stock Titan
Health Catalyst (NASDAQ: HCAT) CPO gets RSU, PRSU grants and tax sell-to-cover - Stock Titan
Large stock grants and tax-driven share sale at Health Catalyst (HCAT) - Stock Titan
Health Catalyst (HCAT) CFO receives major RSU awards, sells shares for taxes - Stock Titan
FOMO Trade: Should I set a stop loss on Health Catalyst Inc2025 Biggest Moves & Safe Entry Zone Identification - baoquankhu1.vn
Benjamin Landry to sell 6,317 HCAT restricted shares (HCAT) - Stock Titan
Health Catalyst (HCAT) insider sale notice: 4,471 shares via Morgan Stanley - Stock Titan
Health Catalyst (HCAT) Form 144: 7,522 restricted shares proposed for sale - Stock Titan
Health Catalyst, Inc (HCAT) Stock Analysis: Potential Upside of 116% Piques Investor Interest - DirectorsTalk Interviews
HCAT PE Ratio & Valuation, Is HCAT Overvalued - Intellectia AI
How The Health Catalyst (HCAT) Story Is Shifting After Target Cut And CEO Transition - Yahoo Finance
Whetstone Capital Advisors, LLC Increases Stake in Health Cataly - GuruFocus
HCAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Health Catalyst Names New CEO Amid Board Restructuring - TipRanks
What are Health Catalyst Inc.’s recent SEC filings showingPortfolio Return Summary & Low Drawdown Investment Ideas - mfd.ru
Health Catalyst Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):